PGEN News and Press, Precigen Inc. From 09/03/25

2025-09-03 07:45:17 ET More on Precigen Precigen, Inc. - Special Call Precigen: This Billion-Dollar Approval Is Still Undervalued Precigen: August Is Pivotal For This Biotech Innovator Precigen surges on FDA approval for immunotherapy Seeking Alpha&#x...

Precigen Announces Up to $125 Million Non-Dilutive Financing PR Newswire $100 million funded at close fortifies balance sheet and supports robust US commercialization of PAPZIMEOS, as well as potential expansion into international markets and the pursuit of pediatric and o...

2025-09-02 13:55:07 ET Precigen, Inc. - Special Call Company Participants Helen Sabzevari - President, CEO & Director Phil Tennant - Chief Commercial Officer ... Read the full article on Seeking Alpha For further details see: Precigen, Inc. - Specia...

2025-08-27 13:04:13 ET Inovio Pharmaceuticals ( INO ) had a slight setback with its timeline on when it could actually file its Biologics License Application [BLA] of INO-3107 for the treatment of patients with recurrent respiratory papillomatosis [RRP]. The last time I covered this...

Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright PR Newswire GERMANTOWN, Md. , Aug. 25, 2025 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the advancement of innovativ...

A look at the top 10 most actives in the United States SRX Health Solutions Inc. (SRXH) rose 84.6% to $0.5 on volume of 661,499,268 shares Opendoor Technologies Inc (OPEN) rose 4.3% to $3.17 on volume of 410,900,970 shares Perfect Moment Ltd. (PMNT) rose 91.6% to $0.5563 on volume of 316,77...

2025-08-15 15:52:39 ET DENVER, Colo., Aug 15, 2025 ( 247marketnews.com )- With Wall Street barreling toward the weekend, a group of breakout names is looking to close the week at or near fresh 52-week highs . Biotech name Precigen (NASDAQ:PGEN) is holding gains near its 52-w...

2025-08-15 15:15:01 ET Precigen - An Introduction My last analysis of Precigen, Inc. ( PGEN ) was two years ago. Back then, I upgraded PGEN from Hold to Buy after the company established a rapid and viable path towards advancing its lead immunotherapy candidate, PRGN-201...

2025-08-15 14:53:09 ET DENVER, Colo., Aug 15, 2025 ( 247marketnews.com )- As we approach the final stretch of Tuesday’s trading session, momentum is building across the biotech/biopharma and solar/energy sectors, with several names lining up for potential after-hours fire...

2025-08-15 10:24:13 ET DENVER, Colo., Aug 15, 2025 ( 247marketnews.com )- Wall Street kicked off another jam-packed day of earnings reports, biotech breakthroughs, and strategic momentum that could set the tone for the back half of the year. VENU’s (NYSE:VENU) second-quar...